Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

FDA Grants Orphan Drug Designation to BA-101 in Glioblastoma

September 8th 2025, 3:02pm

Article

The FDA has granted orphan drug designation to the investigational therapy BA-101 for the treatment of patients with glioblastoma.

Every Oncologic FDA Approval Throughout August 2025

September 2nd 2025, 7:00pm

Article

In August 2025, the FDA approved various anti-cancer treatments across a range of disease types, such as colorectal, lung cancer and brain cancer.

Non-Drug Therapies and Support Improve Cancer Care Outcomes

August 26th 2025, 7:00pm

Article

Non-drug therapies, counseling and telehealth improved pain, mood and communication in cancer care, though older adults and minorities remain underrepresented.

FDA Approval of Modeyso For Glioma May Lead to Combination Therapies

August 23rd 2025, 6:00pm

Article

The FDA’s accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation sets the stage for more treatment advancements.

CAR T Being Explored in Glioma Following Successes in Blood Cancer

August 20th 2025, 1:00pm

Video

CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.

Financial and Educational Disparities Persist in Glioblastoma Care

August 16th 2025, 2:00pm

Article

A nationwide survey of patients and caregivers has found educational and financial disparities in brain cancer care.

FDA Approval of Modeyso ‘Important Step Forward’ For Patients with Glioma

August 15th 2025, 1:00pm

Video

The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but more work remains.

FDA Approves Modeyso for Patients with Diffuse Midline Glioma

August 6th 2025, 6:55pm

Article

The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.

A Little Off the Top: the First Step in a Brain Cancer Journey

July 26th 2025, 2:00pm

Article

After surviving brain surgery, I found clarity, strength, and unexpected joy; facing my fears became the turning point, not the diagnosis.

Just a Little Off the Top: Taking the First Step in the Cancer Journey

July 25th 2025, 9:00pm

Article

After brain surgery for a malignant tumor, I faced fears, found strength, and embraced living in the moment as I begin treatment and healing.